Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery-Reference-Cited by-同舟云学术

Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery

Published:2017-06-21 Issue:7 Volume:50 Page:1606-1616
ISSN:0001-4842
Container-title:Accounts of Chemical Research
language:en
Short-container-title:Acc. Chem. Res.

Author:

Okombo John¹,Chibale Kelly¹²^ORCID

Affiliation:

1. Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa

2. South African Medical Research Council Drug Discovery and Development Research Unit, Drug Discovery and Development Centre (H3D), Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa

Funder

Bill and Melinda Gates Foundation

Medicines for Malaria Venture

University of Cape Town

Department of Science and Technology, Republic of South Africa

National Research Foundation

South African Medical Research Council

Novartis Research Foundation

Publisher

American Chemical Society (ACS)

Subject

General Medicine,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.accounts.6b00631

Reference51 articles.

1. World Health Organization (WHO). World Malaria Report, 2016; Geneva, Switzerland (accessed Dec 5, 2016) .

2. World Health Organization (WHO). Global Tuberculosis Report 2016; Geneva, Switzerland (accessed Dec 5, 2016) .

3. Artemisinin Resistance inPlasmodium falciparumMalaria

4. Evidence of Artemisinin-Resistant Malaria in Western Cambodia

5. World Health Organization (WHO). Global Tuberculosis Report 2014; Geneva, Switzerland (accessed Dec 5, 2016) .

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of DXR in the MEP pathway with lipophilic N-alkoxyaryl FR900098 analogs;RSC Medicinal Chemistry;2024

2. Recent advances on patents of Plasmodium falciparum dihydroorotate dehydrogenase ( Pf DHODH) inhibitors as antimalarial agents;Expert Opinion on Therapeutic Patents;2023-09-02

3. Medicinal chemistry approaches for the discovery of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors as antimalarial agents;Future Medicinal Chemistry;2023-07

4. Advances in computational frameworks in the fight against TB: The way forward;Frontiers in Pharmacology;2023-04-03

5. New targets for antimalarial drug discovery;Current Opinion in Microbiology;2022-12